Tagged

PMHNP Prescribing

Real talk about psychopharmacology, clinical confidence, and building a practice you love — from Lindsay and the Fellowship faculty.

Editorial still-life of a small unbranded plain glass medical vial with a smooth metallic crimp top standing upright on a quiet pale clinical countertop representing a long-acting injectable antipsychotic formulation, a small unbranded plain disposable syringe with a sheathed needle resting flat horizontally beside the vial representing the injection itself, a small shallow round amber-tinted glass dish to the side holding three small smooth round white tablets representing the tapering oral antipsychotic overlap, a small simple sealed brushed-metal sharps container in the background representing safe injection practice, and a small ruled cream paper notepad in the foreground with a thin black fountain pen resting diagonally across it representing the PMHNP transition protocol notes — header illustration for a 2026 PMHNP clinical-practice guide on switching patients from oral antipsychotics to long-acting injectables.

Clinical Practice

LAI Antipsychotics: 2026 PMHNP Transition Protocol

PMHNP step-by-step protocol for switching oral antipsychotics to long-acting injectables in 2026: aripiprazole, paliperidone, risperidone overlap.

June 2, 2026 Read More →

Editorial still-life of a small smooth empty amber prescription bottle standing upright on a quiet wooden bedside table at evening representing prazosin prescribed for PTSD nightmares, a small simple analog desk clock viewed from the front showing late evening hours representing bedtime dosing, a soft folded woven cream wool blanket draped lightly across one corner of the table representing restorative sleep, a small bedside reading lamp casting a warm focused circle of light from above creating a calm pool of light on the table, and a small closed ruled cream paper sleep journal with a thin black fountain pen resting diagonally across it representing nightmare-frequency tracking — header illustration for a 2026 PMHNP clinical guide on the prazosin titration protocol for PTSD-related nightmares.

Clinical Practice

Prazosin for PTSD Nightmares: 2026 PMHNP Titration Protocol

85% of patients on prazosin for PTSD nightmares are underdosed. The 2026 PMHNP titration ladder, sex-specific target doses, and orthostatic safety floor.

May 22, 2026 Read More →

DEA telehealth prescribing rules for PMHNPs in 2026 - laptop with stethoscope representing telepsychiatry

Industry

DEA Telehealth Prescribing in 2026: What PMHNPs Must Know

DEA telehealth prescribing flexibilities expire December 31, 2026. Learn what PMHNPs need to know about controlled substance rules and how to prepare.

April 12, 2026 Read More →

PMHNP Prescribing

LAI Antipsychotics: 2026 PMHNP Transition Protocol

Prazosin for PTSD Nightmares: 2026 PMHNP Titration Protocol

DEA Telehealth Prescribing in 2026: What PMHNPs Must Know

Join the Fellowship today.